 |
|
Clinical Trials
Clinical trials are controlled studies designed to test and evaluate efficacy of new treatment for a particular disease. We have been conducting clinical trials at the Diabetes Unit since 1999. All subjects in clinical trials are carefully monitored. Frequent medical exams and tests are performed to assure their safety.
By participating in clinical trials people can contribute to medical science and help doctors and researchers find better ways to treat various diseases. Researchers follow strict ethical and scientific protocols in order to make sure that patients are protected and valid results are produced.
To ensure patient safety, the protocol is reviewed and approved by the ethical committee of K.E.M. Hospital Research Centre.
A full list of clinical trials conducted at the Diabetes Unit is given in the table to the right.
|
|
©Diabetes Unit KEM Hospital Pune. All Rights Reserved
Home | About Us | Research | Collaborations | Publications | Contact
|
|
|
| Research Centre |
|
| Daycare Centre |
|
| Clinical Trials |
|
| Team |
|
| Facilities & Support |
|
| Clinical Trials Conducted |
| CRO/Sponsors |
Protocol No. |
Year |
| Torrent |
|
1999 |
| Eli- Lilly(IND) |
|
2000 |
| Eli Lilly(IONL) |
|
2001 |
| Eli Lilly(humapen) |
|
2004 |
| GlipiZide/Pioglitazone |
|
2001 |
| Pfizer (Gourdine Study) |
|
2002 |
| Dream Trail(Aventis) |
|
2003 |
| Novartis |
CLAF237A2355 |
2005 |
| Clinigene/Merck |
MK-0431 801 -00 |
2006 |
| Novartis |
CLAF237A2302 |
2006 |
| Eli- Lily(HIIP) |
H7U-MC-IDAU(a) |
2006 |
| Quintiles/Eli Lily |
H7U-MC-IDAS |
2006 |
| Chiltern |
CL3-00780-148 |
2006 |
| Icon/ BMS |
CV181-013 |
2006 |
| Icon /BMS |
CV181-039 |
2006 |
| Icon .Metabolex |
M102-20509 |
2006 |
| Novartis |
CSPP100 E2337 |
2008 |
| Amylin |
BCB106 |
2008 |
| BMS |
MB102029 |
2008 |
| GSK |
GLP112757 |
2009 |
| Merck |
TECOS 08200 |
2009 |
| Eli Lilly |
GBCF |
2010 |
| Quintiles |
EISAI |
2010 |
| Teplizumab |
T1DM |
2010 |
| J&J |
CANVAS |
2010 |
| Biocon |
EMEA Insugen |
2010 |
| Boehringer Ingelheim |
BI 1245-28 |
2010 |
|
|
|
